Ferah Tuncel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ferah Tuncel has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Necmiye Canacankatan
Department of Biochemistry, Faculty of Pharmacy, Mersin University, Mersin, Turkey
5 shared publications - Şerife Efsun Antmen
Mersin Universitesi
5 shared publications - Cem Yalaza
Department of Biochemistry, Faculty of Pharmacy, Başkent University, 06790 Ankara, Türkiye
4 shared publications - Hakan Aytan
Department of Obstetrics and Gynecology, Faculty of Medicine, Mersin University, 33110 Mersin, Turkey
4 shared publications - Sema Erden Ertürk
Mersin Universitesi
4 shared publications - Cumhur Özcan
Department of Surgery, Mersin University School of Medicine, Mersin, Turkey
3 shared publications
Latest Publications
- Open Access
- 10 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (24) , 11923
Expression Alterations and Correlative Analysis of TPH1/hsa-miR-194-5p/NEAT1 and MAOA/hsa-miR-1276/NEAT1 Axes in Pediatric Inflammatory Bowel Disease
Pediatric inflammatory bowel disease (pIBD), comprising ulcerative colitis (UC) and Crohn’s disease (CD), involves complex mechanisms that include non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), alongside enzymes regulating serotonin metabolism. Tryptophan hydroxylase 1 (TPH1) and monoamine oxidase A (MAOA) play critical roles in serotonin turnover and may contribute to intestinal inflammation. We investigated the expression of TPH1, MAOA, hsa-miR-194-5p, hsa-miR-1276, and the lncRNA Nuclear Enriched Abundant Transcript 1 (NEAT1) in intestinal tissue biopsies and peripheral blood from pIBD patients and controls. TPH1 was significantly elevated in the inflamed transverse colon (p = 0.034), whereas MAOA was reduced in the ileum (p = 0.041) and descending colon (p = 0.001), with further decreases in inflamed ileum (p < 0.001), ascending (p = 0.008), and descending colon (p = 0.001). Subgroup analysis revealed decreased MAOA in the ascending colon of UC patients (p = 0.011). hsa-miR-194-5p was upregulated in the transverse colon (p = 0.015), inflamed transverse (p = 0.013) and descending colon (p = 0.015), and in blood of UC patients (p = 0.01). NEAT1 expression increased in the ascending colon (p = 0.042) but decreased in the ileum (p = 0.006). Correlation analysis showed strong positive associations between TPH1 and NEAT1 in the ileum (r = 0.945, p < 0.01) and transverse colon (r = 0.609, p < 0.01). These results highlight region-specific dysregulation of serotonin-related genes and ncRNAs in pIBD, with the TPH1/miR-194-5p/NEAT1 axis potentially contributing to disease pathophysiology and warranting further mechanistic investigation.
- 10 December 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (24) , 11923
Open AccessExpression Alterations and Correlative Analysis of TPH1/hsa-miR-194-5p/NEAT1 and MAOA/hsa-miR-1276/NEAT1 Axes in Pediatric Inflammatory Bowel Disease
Pediatric inflammatory bowel disease (pIBD), comprising ulcerative colitis (UC) and Crohn’s disease (CD), involves complex mechanisms that include non-coding RNAs (ncRNAs), such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), alongside enzymes regulating serotonin metabolism. Tryptophan hydroxylase 1 (TPH1) and monoamine oxidase A (MAOA) play critical roles in serotonin turnover and may contribute to intestinal inflammation. We investigated the expression of TPH1, MAOA, hsa-miR-194-5p, hsa-miR-1276, and the lncRNA Nuclear Enriched Abundant Transcript 1 (NEAT1) in intestinal tissue biopsies and peripheral blood from pIBD patients and controls. TPH1 was significantly elevated in the inflamed transverse colon (p = 0.034), whereas MAOA was reduced in the ileum (p = 0.041) and descending colon (p = 0.001), with further decreases in inflamed ileum (p < 0.001), ascending (p = 0.008), and descending colon (p = 0.001). Subgroup analysis revealed decreased MAOA in the ascending colon of UC patients (p = 0.011). hsa-miR-194-5p was upregulated in the transverse colon (p = 0.015), inflamed transverse (p = 0.013) and descending colon (p = 0.015), and in blood of UC patients (p = 0.01). NEAT1 expression increased in the ascending colon (p = 0.042) but decreased in the ileum (p = 0.006). Correlation analysis showed strong positive associations between TPH1 and NEAT1 in the ileum (r = 0.945, p < 0.01) and transverse colon (r = 0.609, p < 0.01). These results highlight region-specific dysregulation of serotonin-related genes and ncRNAs in pIBD, with the TPH1/miR-194-5p/NEAT1 axis potentially contributing to disease pathophysiology and warranting further mechanistic investigation.
- Open Access
- 28 November 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (12) , 667
Axillary Pathological Complete Response After Neoadjuvant Therapy in cN1–2 Breast Cancer: An Internally Validated PET/CT-Integrated Nomogram
We aimed to develop and internally validate a nomogram to estimate axillary pathological complete response (pCR, ypN0) after neoadjuvant systemic therapy (NAST) in clinically node-positive (cN1–2) breast cancer. In a single-center retrospective cohort of 144 consecutive patients treated with NAST (anti-HER2 as indicated), all underwent standardized pre- and post-NAST 18F-FDG PET/CT and axillary staging (sentinel lymph node biopsy [SLNB], targeted axillary dissection [TAD], or axillary lymph node dissection [ALND]). Axillary pCR occurred in 51.4% (74/144). In a multivariable analysis, independent positive determinants of ypN0 included the triple-negative subtype, Modified PERCIST (SUVmax-based) reduction ≥ 80.70%, pre-NAST tumor-to-axilla SUVmax ratio ≥ 1.21, and residual breast tumor size < 0.5 mm; conversely, conglomerate/matted nodal morphology at diagnosis was inversely associated. The model showed good internal discrimination (AUC 0.857, 95% CI 0.797–0.917) and acceptable calibration (Hosmer–Lemeshow p = 0.425). Exploratory, subtype-restricted signals were observed for inflammatory indices within Luminal B (HER2+) but were not retained in the final model. The resulting nomogram—combining tumor biology, PET/CT response, and pre-NAST nodal features—may support risk stratification for axillary de-escalation after NAST; however, prospective external validation—ideally embedded in ongoing de-escalation frameworks—remains essential before clinical implementation, and the tool should currently be regarded as hypothesis-generating rather than a stand-alone decision aid for routine practice.
- 28 November 2025
- Published by MDPI AG in Current Oncology
- Vol. 32 (12) , 667
Open AccessAxillary Pathological Complete Response After Neoadjuvant Therapy in cN1–2 Breast Cancer: An Internally Validated PET/CT-Integrated Nomogram
We aimed to develop and internally validate a nomogram to estimate axillary pathological complete response (pCR, ypN0) after neoadjuvant systemic therapy (NAST) in clinically node-positive (cN1–2) breast cancer. In a single-center retrospective cohort of 144 consecutive patients treated with NAST (anti-HER2 as indicated), all underwent standardized pre- and post-NAST 18F-FDG PET/CT and axillary staging (sentinel lymph node biopsy [SLNB], targeted axillary dissection [TAD], or axillary lymph node dissection [ALND]). Axillary pCR occurred in 51.4% (74/144). In a multivariable analysis, independent positive determinants of ypN0 included the triple-negative subtype, Modified PERCIST (SUVmax-based) reduction ≥ 80.70%, pre-NAST tumor-to-axilla SUVmax ratio ≥ 1.21, and residual breast tumor size < 0.5 mm; conversely, conglomerate/matted nodal morphology at diagnosis was inversely associated. The model showed good internal discrimination (AUC 0.857, 95% CI 0.797–0.917) and acceptable calibration (Hosmer–Lemeshow p = 0.425). Exploratory, subtype-restricted signals were observed for inflammatory indices within Luminal B (HER2+) but were not retained in the final model. The resulting nomogram—combining tumor biology, PET/CT response, and pre-NAST nodal features—may support risk stratification for axillary de-escalation after NAST; however, prospective external validation—ideally embedded in ongoing de-escalation frameworks—remains essential before clinical implementation, and the tool should currently be regarded as hypothesis-generating rather than a stand-alone decision aid for routine practice.
- Open Access
- 21 November 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (23)
Measuring Surgical Waiting Times in Breast Cancer: Admission to Surgery Versus Biopsy Result to Surgery
Background: Preoperative timelines may lengthen due to tailored evaluation and system constraints. We examined whether two complementary measures of time-to-surgery (TTS)—admission-to-surgery (A-TTS) and biopsy-result-to-surgery (B-TTS)—behave similarly and whether parallel tracking offers service value. Methods: In a single-center retrospective cohort of eligible women undergoing upfront surgery for invasive breast cancer (2010–2021; n = 167), we reported quality indicators for timeliness (target attainment, agreement and discordance, the interval gap, and the surgery-to-adjuvant interval), while analyzing recurrence as the primary endpoint and overall survival as secondary. Discrimination analyses, logistic regression, and Cox models were used; non-proportional hazards were handled with a log–time interaction centered at 24 months. Results: The two time measures were not interchangeable: discordant cases were frequent and pointed to different bottlenecks. A-TTS ≤ 24 days was independently associated with recurrence (OR 3.16; 95% CI 1.13–8.82) and showed a large early hazard for death at 24 months that attenuated over time (HR 22.83; 95% CI 6.44–80.98; interaction HR 0.06; 95% CI 0.02–0.21), whereas B-TTS showed no association. Conclusions: Lymphovascular invasion remained the strongest pathologic correlate of survival. Tracking both intervals, paired with brief, reason-coded reviews of discordant cases, may support scheduling, quality dashboards, and breach governance better than a single TTS metric.
- 21 November 2025
- Published by MDPI AG in Healthcare
- Vol. 13 (23)
Open AccessMeasuring Surgical Waiting Times in Breast Cancer: Admission to Surgery Versus Biopsy Result to Surgery
Background: Preoperative timelines may lengthen due to tailored evaluation and system constraints. We examined whether two complementary measures of time-to-surgery (TTS)—admission-to-surgery (A-TTS) and biopsy-result-to-surgery (B-TTS)—behave similarly and whether parallel tracking offers service value. Methods: In a single-center retrospective cohort of eligible women undergoing upfront surgery for invasive breast cancer (2010–2021; n = 167), we reported quality indicators for timeliness (target attainment, agreement and discordance, the interval gap, and the surgery-to-adjuvant interval), while analyzing recurrence as the primary endpoint and overall survival as secondary. Discrimination analyses, logistic regression, and Cox models were used; non-proportional hazards were handled with a log–time interaction centered at 24 months. Results: The two time measures were not interchangeable: discordant cases were frequent and pointed to different bottlenecks. A-TTS ≤ 24 days was independently associated with recurrence (OR 3.16; 95% CI 1.13–8.82) and showed a large early hazard for death at 24 months that attenuated over time (HR 22.83; 95% CI 6.44–80.98; interaction HR 0.06; 95% CI 0.02–0.21), whereas B-TTS showed no association. Conclusions: Lymphovascular invasion remained the strongest pathologic correlate of survival. Tracking both intervals, paired with brief, reason-coded reviews of discordant cases, may support scheduling, quality dashboards, and breach governance better than a single TTS metric.
- Open Access
- 15 September 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 21 (5) , 2079-2087
Triple-Negative Breast Cancer and Ferroptosis: Expression Profiling of Key Regulatory Genes
Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Ferroptosis, a regulated form of cell death driven by lipid peroxidation, has emerged as a potential therapeutic target. This study aimed to evaluate the expression levels of ferroptosis-associated genes GPX4, ACSL4, and BCAT2 in TNBC tissues and to investigate their potential as diagnostic or therapeutic biomarkers.Material and methods: A total of 100 formalin-fixed paraffin-embedded (FFPE) breast tissue samples were analyzed, including 60 TNBC patient samples and 40 healthy controls. Gene expression levels of GPX4, ACSL4, and BCAT2 were determined using RT-qPCR. Statistical comparisons were conducted using the Mann–Whitney U test, and correlation analyses were performed using Spearman’s test.Results: The expression levels of GPX4, ACSL4, and BCAT2 were significantly decreased in the TNBC group compared to controls (p = 0.0001 for all genes). Strong positive correlations were observed among the three genes, with BCAT2 showing the highest correlation with both GPX4 (R=0.636) and ACSL4 (R=0.683). Additionally, BCAT2 expression negatively correlated with tumor diameter and Ki-67 index.Conclusions: The significant downregulation and strong positive correlation of GPX4, ACSL4, and BCAT2 in TNBC tissues suggest a coordinated suppression of ferroptosis. These findings highlight the potential of targeting ferroptosis as a novel therapeutic strategy in TNBC and propose these genes as candidate biomarkers for diagnosis and treatment response.
- 15 September 2025
- Published by Termedia Sp. z.o.o. in Archives of Medical Science
- Vol. 21 (5) , 2079-2087
Open AccessTriple-Negative Breast Cancer and Ferroptosis: Expression Profiling of Key Regulatory Genes
Introduction: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2). Ferroptosis, a regulated form of cell death driven by lipid peroxidation, has emerged as a potential therapeutic target. This study aimed to evaluate the expression levels of ferroptosis-associated genes GPX4, ACSL4, and BCAT2 in TNBC tissues and to investigate their potential as diagnostic or therapeutic biomarkers.Material and methods: A total of 100 formalin-fixed paraffin-embedded (FFPE) breast tissue samples were analyzed, including 60 TNBC patient samples and 40 healthy controls. Gene expression levels of GPX4, ACSL4, and BCAT2 were determined using RT-qPCR. Statistical comparisons were conducted using the Mann–Whitney U test, and correlation analyses were performed using Spearman’s test.Results: The expression levels of GPX4, ACSL4, and BCAT2 were significantly decreased in the TNBC group compared to controls (p = 0.0001 for all genes). Strong positive correlations were observed among the three genes, with BCAT2 showing the highest correlation with both GPX4 (R=0.636) and ACSL4 (R=0.683). Additionally, BCAT2 expression negatively correlated with tumor diameter and Ki-67 index.Conclusions: The significant downregulation and strong positive correlation of GPX4, ACSL4, and BCAT2 in TNBC tissues suggest a coordinated suppression of ferroptosis. These findings highlight the potential of targeting ferroptosis as a novel therapeutic strategy in TNBC and propose these genes as candidate biomarkers for diagnosis and treatment response.
- 21 February 2025
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 83 (3) , 3125-3136
‘Investigation of miRNAs That Affect the PI3K/AKT/mTOR Signaling Pathway in Endometrial Cancer’
Endometrial cancer is a prevalent type of cancer among women worldwide. The irregularity of the PI3K/AKT/mTOR signaling pathway plays a role in the pathogenesis of many cancer types. MicroRNAs are small noncoding RNAs that play crucial roles in the pathogenesis of different cancer types. MicroRNAs target many key components of the PI3K/AKT/mTOR pathway in human tumors. In this study the PI3K/AKT/mTOR pathway was affected in endometrial cancer, and the expression levels of miR-7, miR-17, miR-145, miR-155, miR-206, miR-221, miR-222 were determined. In addition, in silico analyses were examine the molecular interactions between miRNAs and target genes. Identifying dysregulated miRNA expression in endometrial cancer is important for developing miRNA-based therapeutic strategies. In our study, Grade 1 (n = 16), Grade 2 (n = 16), Grade 3 (n = 16), tissues diagnosed with endometrioid adeno carcinoma, control 1 (n = 16) secretory phase and control 2 (n = 16) proliferative phase healthy endometrial tissues without endometrial cancer were included. miRNA expression analysis was performed using the real-time PCR. In our study, the expression of miR-7-5p, miR-145-5p, and miR-206 decreased, whereas the expression of miR-17-5p, miR-221-3p, and miR-222-3p increased in endometrial cancer (p < 0,05). Statistically significant results were not obtained to for the expression levels of miR-21-5p and miR-155-5p. miR-7-5p targets PIK3CD, PIK3R3, PIK3CB and AKT3, miR-17-5p targets PIK3R1 and AKT3, miR-21-5p target PIK3R1, miR-145-5p target AKT3, miR-155-5p targets PIK3CA and PIK3R1, miR-206 target PIK3C2A, miR-221-3p and miR-222-3p target PIK3R1 as identified via in silico analysis. These results can shed light on the development of molecular-targeted therapy strategies. Treatment strategies can be developed by designing ASOs, LNAs, miRNA antagomirs, or miRNA sponges for upregulated miR-17-5p, miR-221-3p, and miR-222-3p, and miRNA mimics for downregulated miR-7-5p, miR-145-5p, and miR-206.
- 21 February 2025
- Published by Springer Nature in Cell Biochemistry and Biophysics
- Vol. 83 (3) , 3125-3136
‘Investigation of miRNAs That Affect the PI3K/AKT/mTOR Signaling Pathway in Endometrial Cancer’
Endometrial cancer is a prevalent type of cancer among women worldwide. The irregularity of the PI3K/AKT/mTOR signaling pathway plays a role in the pathogenesis of many cancer types. MicroRNAs are small noncoding RNAs that play crucial roles in the pathogenesis of different cancer types. MicroRNAs target many key components of the PI3K/AKT/mTOR pathway in human tumors. In this study the PI3K/AKT/mTOR pathway was affected in endometrial cancer, and the expression levels of miR-7, miR-17, miR-145, miR-155, miR-206, miR-221, miR-222 were determined. In addition, in silico analyses were examine the molecular interactions between miRNAs and target genes. Identifying dysregulated miRNA expression in endometrial cancer is important for developing miRNA-based therapeutic strategies. In our study, Grade 1 (n = 16), Grade 2 (n = 16), Grade 3 (n = 16), tissues diagnosed with endometrioid adeno carcinoma, control 1 (n = 16) secretory phase and control 2 (n = 16) proliferative phase healthy endometrial tissues without endometrial cancer were included. miRNA expression analysis was performed using the real-time PCR. In our study, the expression of miR-7-5p, miR-145-5p, and miR-206 decreased, whereas the expression of miR-17-5p, miR-221-3p, and miR-222-3p increased in endometrial cancer (p < 0,05). Statistically significant results were not obtained to for the expression levels of miR-21-5p and miR-155-5p. miR-7-5p targets PIK3CD, PIK3R3, PIK3CB and AKT3, miR-17-5p targets PIK3R1 and AKT3, miR-21-5p target PIK3R1, miR-145-5p target AKT3, miR-155-5p targets PIK3CA and PIK3R1, miR-206 target PIK3C2A, miR-221-3p and miR-222-3p target PIK3R1 as identified via in silico analysis. These results can shed light on the development of molecular-targeted therapy strategies. Treatment strategies can be developed by designing ASOs, LNAs, miRNA antagomirs, or miRNA sponges for upregulated miR-17-5p, miR-221-3p, and miR-222-3p, and miRNA mimics for downregulated miR-7-5p, miR-145-5p, and miR-206.
- 17 June 2024
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 21 (2) , 232-237
Encapsulated papillary carcinoma of the breast clinicopathological features and management: Could sentinel lymph node biopsy be exempted?
Background: Papillary lesions in the breast pose diagnostic and therapeutic challenges. Encapsulated papillary carcinoma (EPC) is a rare breast cancer. However, evidence‐based guidelines are limited. For this reason, there is no complete clarity in diagnosis and treatment management, and there are insufficient studies in the literature. This study aimed to examine the necessity of sentinel lymph node sampling in the management of EPC, in line with patients' clinicopathological data.Methods: We retrospectively screened patients with EPC in our clinic between January 2012 and March 2022. We recorded and statistically evaluated patients' demographic, clinical, radiological, pathological, and treatment management.Results: Sixty‐four patients with EPCs were identified. The final pathologic evaluation revealed that 19 patients (18.7%) had pure EPC, 27 patients (43.7%) had EPC with associated ductal carcinoma in situ and 18 patients (37.5%) had EPC associated with invasion. The mean age was 61 years, and two patients were male. Breast‐conserving surgery was performed in 62 patients, and simple mastectomy was performed in two patients. Sentinel lymph node biopsy (SLNB) was positive in only one patient. Sixty‐three patients with EPC were hormone receptor‐positive, and one patient was triple‐negative and was associated with invasion. None of the patients died, one had a local recurrence, and a mastectomy was performed.Conclusions: The overall prognosis and long‐term survival of patients with EPC were excellent. Our study and the current literature indicate that routine SLNB is overtreatment because surgical excision with negative margins is sufficient in EPC cases and lymph node metastasis is rare, even with an invasive component.
- 17 June 2024
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 21 (2) , 232-237
Encapsulated papillary carcinoma of the breast clinicopathological features and management: Could sentinel lymph node biopsy be exempted?
Background: Papillary lesions in the breast pose diagnostic and therapeutic challenges. Encapsulated papillary carcinoma (EPC) is a rare breast cancer. However, evidence‐based guidelines are limited. For this reason, there is no complete clarity in diagnosis and treatment management, and there are insufficient studies in the literature. This study aimed to examine the necessity of sentinel lymph node sampling in the management of EPC, in line with patients' clinicopathological data.Methods: We retrospectively screened patients with EPC in our clinic between January 2012 and March 2022. We recorded and statistically evaluated patients' demographic, clinical, radiological, pathological, and treatment management.Results: Sixty‐four patients with EPCs were identified. The final pathologic evaluation revealed that 19 patients (18.7%) had pure EPC, 27 patients (43.7%) had EPC with associated ductal carcinoma in situ and 18 patients (37.5%) had EPC associated with invasion. The mean age was 61 years, and two patients were male. Breast‐conserving surgery was performed in 62 patients, and simple mastectomy was performed in two patients. Sentinel lymph node biopsy (SLNB) was positive in only one patient. Sixty‐three patients with EPC were hormone receptor‐positive, and one patient was triple‐negative and was associated with invasion. None of the patients died, one had a local recurrence, and a mastectomy was performed.Conclusions: The overall prognosis and long‐term survival of patients with EPC were excellent. Our study and the current literature indicate that routine SLNB is overtreatment because surgical excision with negative margins is sufficient in EPC cases and lymph node metastasis is rare, even with an invasive component.
- Open Access
- 25 December 2023
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 21 (3) , 219-223
Efficacy of ABCA1 Transporter Proteins in Endometrial Cancer
Objectives: Endometrial carcinoma (EC) is a typical gynecological malignant tumor that occurs more frequently every year. Obesity is a significant contributor to the development of EC and its prognosis. Lipid metabolism and malignant tumors have a long history of association. Elevated cholesterol levels are made possible by adenosine triphosphate-binding cassette protein A1 (ABCA1) deficiency, which eventually promotes cancer cell survival. The aim of this study was to examine at the ABCA1 gene expression levels in EC patients. The relationship between ABCA1 and the occurrence, progression, and prognosis of EC is discussed in this article as a potential mechanism. Materials and Methods: The samples of 45 endometrial adenocarcinoma patients were retrospectively included in this study and they were further divided into Grade 1 (15), Grade 2 (15), Grade 3 (15) tumors, control group. Twenty-nine endometrial tissues without a confirmed diagnosis of endometrial cancer made up the control group. ABCA1 gene expression was examined using real-time polymerase chain reaction. Results: According to the results, the gene expressions of the patient group were higher than the control group When each Grade was compared with the control group, statistically significant results were obtained. After analyzing the data, it was found that the patient group was generally higher than the control group (p < 0.05) and there were differences in the grades of the patient group (p < 0.05). When the ABCA1 expressions of the grade groups and control groups were compared separately, a difference was found between Grade 1, Grade 2 and Grade 3 and the control group (p= 0.0001). Conclusion: According to the findings of our study, a key component in the growth of EC tumors is the increase in cholesterol production caused by a reduction in ABCA1.
- 25 December 2023
- Published by Galenos Yayinevi in Turkish Journal of Pharmaceutical Sciences
- Vol. 21 (3) , 219-223
Open AccessEfficacy of ABCA1 Transporter Proteins in Endometrial Cancer
Objectives: Endometrial carcinoma (EC) is a typical gynecological malignant tumor that occurs more frequently every year. Obesity is a significant contributor to the development of EC and its prognosis. Lipid metabolism and malignant tumors have a long history of association. Elevated cholesterol levels are made possible by adenosine triphosphate-binding cassette protein A1 (ABCA1) deficiency, which eventually promotes cancer cell survival. The aim of this study was to examine at the ABCA1 gene expression levels in EC patients. The relationship between ABCA1 and the occurrence, progression, and prognosis of EC is discussed in this article as a potential mechanism. Materials and Methods: The samples of 45 endometrial adenocarcinoma patients were retrospectively included in this study and they were further divided into Grade 1 (15), Grade 2 (15), Grade 3 (15) tumors, control group. Twenty-nine endometrial tissues without a confirmed diagnosis of endometrial cancer made up the control group. ABCA1 gene expression was examined using real-time polymerase chain reaction. Results: According to the results, the gene expressions of the patient group were higher than the control group When each Grade was compared with the control group, statistically significant results were obtained. After analyzing the data, it was found that the patient group was generally higher than the control group (p < 0.05) and there were differences in the grades of the patient group (p < 0.05). When the ABCA1 expressions of the grade groups and control groups were compared separately, a difference was found between Grade 1, Grade 2 and Grade 3 and the control group (p= 0.0001). Conclusion: According to the findings of our study, a key component in the growth of EC tumors is the increase in cholesterol production caused by a reduction in ABCA1.
- Open Access
- 14 December 2023
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (1) , 131-137
Expression levels of genes involved in lipogenesis and cholesterol synthesis in adenomyosis
Objectives: Adenomyosis is a benign uterine disease that occurs with the invasion of the endometrial gland and stoma into the myometrium. The etiology and molecular pathology of adenomyosis are not yet fully understood. Tissue samples of patients diagnosed with adenomyosis and healthy endometrial tissues were investigated for the lipogenesis and cholesterol synthesis pathways. It was aimed to determine the difference between adenomyosis and healthy endometrial tissues in terms of lipid metabolism and to investigate the mechanism of adenomyosis in this context. Methods: Formalin-fixed paraffin-embedded archival tissues were used in the current retrospective study. A total of 76 patient samples and 3 groups were used. Group 1: adenomyotic tissue (n=28), Group 2: eutopic endometrial tissue (n=30), and Control Group (n=18). In these groups, Sterol regulatory element binding protein 1 ( SREBP1 ) molecule, fatty acid synthase ( FASN ), acetyl-CoA carboxylase ( ACACA ), ATP-citrate lyase ( ACLY ), HMG-CoA reductase ( HMGCR ), and HMG-CoA synthase ( HMGCS ) markers were evaluated by using RT-PCR method. Results: Statistically significant differences (pHMGCR , HMGCS , ACLY , ACACA , and SREBP1 . HMGCR , HMGCS , ACLY , and SREBP1 gene expression levels between Group 1 and Group 2 and HMGCS , ACACA , ACLY , and SREBP1 gene expression levels between Group 1 and Control Group were determined as statistically different. A significant difference was detected only in HMGCR gene expression levels between Group 2 and the Control Group. Conclusions: These results show that genes involved in lipid metabolism may be associated with the molecular pathogenesis of adenomyosis.
- 14 December 2023
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (1) , 131-137
Open AccessExpression levels of genes involved in lipogenesis and cholesterol synthesis in adenomyosis
Objectives: Adenomyosis is a benign uterine disease that occurs with the invasion of the endometrial gland and stoma into the myometrium. The etiology and molecular pathology of adenomyosis are not yet fully understood. Tissue samples of patients diagnosed with adenomyosis and healthy endometrial tissues were investigated for the lipogenesis and cholesterol synthesis pathways. It was aimed to determine the difference between adenomyosis and healthy endometrial tissues in terms of lipid metabolism and to investigate the mechanism of adenomyosis in this context. Methods: Formalin-fixed paraffin-embedded archival tissues were used in the current retrospective study. A total of 76 patient samples and 3 groups were used. Group 1: adenomyotic tissue (n=28), Group 2: eutopic endometrial tissue (n=30), and Control Group (n=18). In these groups, Sterol regulatory element binding protein 1 ( SREBP1 ) molecule, fatty acid synthase ( FASN ), acetyl-CoA carboxylase ( ACACA ), ATP-citrate lyase ( ACLY ), HMG-CoA reductase ( HMGCR ), and HMG-CoA synthase ( HMGCS ) markers were evaluated by using RT-PCR method. Results: Statistically significant differences (pHMGCR , HMGCS , ACLY , ACACA , and SREBP1 . HMGCR , HMGCS , ACLY , and SREBP1 gene expression levels between Group 1 and Group 2 and HMGCS , ACACA , ACLY , and SREBP1 gene expression levels between Group 1 and Control Group were determined as statistically different. A significant difference was detected only in HMGCR gene expression levels between Group 2 and the Control Group. Conclusions: These results show that genes involved in lipid metabolism may be associated with the molecular pathogenesis of adenomyosis.
- Open Access
- 1 September 2023
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 20 (3) , 174-178
Role of acetyl-CoA acetyltransferase 1 expression in the molecular mechanism of adenomyosis
Objective: Adenomyosis is a benign uterine illness characterized by endometrial gland and stromal invasion into the myometrium. Acetyl-CoA acetyltransferase 1 (ACAT1) is an enzyme localized in mitochondria that is involved in ketogenesis and ketolysis processes by reversibly catalyzing the formation of acetoacetyl-CoA from two acetyl-CoA molecules. The current study investigated the expression of the ACAT1 molecule in tissue samples of patients diagnosed with adenomyosis and healthy endometrial tissues. It is aimed to determine the differences in ACAT1 gene expression and in this way to discover the first information about the role of ACAT1 in the development and molecular mechanism of adenomyosis. Materials and Methods: In the current retrospective study, formalin-fixed paraffin-embedded archival tissues were employed. A total of 76 patient samples were included in the study. Of these samples, 28 are adenomyotic tissue (Group I), 30 are eutopic endometrial tissue (Group II), and 18 are the Control Group. In these groups, the expression levels of the ACAT1 gene were determined by the reverse transcription-polymerase chain reaction method. Results: When the expression results of the ACAT1 gene were evaluated, statistically significant differences were found between the groups (p<0.05). There was a difference between Group I-Group II and Group I-Control Group regarding the ACAT1 gene. No statistically significant change was observed between Group II and Control Group. It is a remarkable finding that the expression of ACAT1 in adenomyosis tissue is decreased compared with both eutopic endometrium and control groups tissues. Conclusion: The results suggest that ACAT1 may be associated with the molecular pathogenesis of adenomyosis.
- 1 September 2023
- Published by Galenos Yayinevi in Journal of Turkish Society of Obstetric and Gynecology
- Vol. 20 (3) , 174-178
Open AccessRole of acetyl-CoA acetyltransferase 1 expression in the molecular mechanism of adenomyosis
Objective: Adenomyosis is a benign uterine illness characterized by endometrial gland and stromal invasion into the myometrium. Acetyl-CoA acetyltransferase 1 (ACAT1) is an enzyme localized in mitochondria that is involved in ketogenesis and ketolysis processes by reversibly catalyzing the formation of acetoacetyl-CoA from two acetyl-CoA molecules. The current study investigated the expression of the ACAT1 molecule in tissue samples of patients diagnosed with adenomyosis and healthy endometrial tissues. It is aimed to determine the differences in ACAT1 gene expression and in this way to discover the first information about the role of ACAT1 in the development and molecular mechanism of adenomyosis. Materials and Methods: In the current retrospective study, formalin-fixed paraffin-embedded archival tissues were employed. A total of 76 patient samples were included in the study. Of these samples, 28 are adenomyotic tissue (Group I), 30 are eutopic endometrial tissue (Group II), and 18 are the Control Group. In these groups, the expression levels of the ACAT1 gene were determined by the reverse transcription-polymerase chain reaction method. Results: When the expression results of the ACAT1 gene were evaluated, statistically significant differences were found between the groups (p<0.05). There was a difference between Group I-Group II and Group I-Control Group regarding the ACAT1 gene. No statistically significant change was observed between Group II and Control Group. It is a remarkable finding that the expression of ACAT1 in adenomyosis tissue is decreased compared with both eutopic endometrium and control groups tissues. Conclusion: The results suggest that ACAT1 may be associated with the molecular pathogenesis of adenomyosis.
- Open Access
- 15 December 2021
- Published by Mersin Universitesi Saglik Bilimleri Dergisi in Mersin Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 14 (3) , 475-483
Assessment of colonoscopic findings in pediatric patients; A single center experience
Amaç: Çalışmada, kolonoskopi yapılan çocuk hastalarda başvuru semptomları, işlem endikasyonları, sonuçlar ve komplikasyonların değerlendirilmesi amaçlandı. Yöntem: Çalışmaya Ocak 2008 ile Aralık 2020 tarihleri arasında kolonoskopi yapılan 0-18 yaş arası hastalar dahil edildi. Hastaların demografik özellikleri, kolonoskopi ve patoloji sonuçları geriye dönük incelendi. Bulgular: Çalışmaya dahil edilen 489 hastanın ortalama yaşı 12.39±4.32 yıl, %57.4’ü erkek, %42.6’sı kızdı. Hastaların 408’inde ≥1 semptom vardı. En sık üç semptom; rektal kanama (n=265, %54.1), karın ağrısı (n=187, %38.2) ve kanlı mukuslu dışkılamaydı (n=112, %22.9). Başlıca kolonoskopi endikasyonu inflamatuvar bağırsak hastalığı (İBH) şüphesi (n=212, %43.3), alt gastrointestinal sistemde kanama (n=145, %29.6) ve kronik ishaldi (n=59, %12). En sık iki tanı İBH (n=88, %17.9) ve polipti (n=31,%6.3). İnflamatuvar bağırsak hastalığı saptananların 46’sında (%9.4) ülseratif kolit, 32’sinde (%6.5) Crohn hastalığı ve 11’inde (%2.2) sınıflandırılamayan İBH olduğu belirlendi. Poliplerin en sık (%74.1) rektosigmoid kolonda yerleşim gösterdiği, %61.2’sinin juvenil polip olduğu saptandı. Sonuçları normal olan 272 (%55.6) hastada en sık iki semptomun rektal kanama (n=91, %62.7) ve ishal (n=31, %52.5), en sık bulgunun da anemi olduğu saptandı (n=25, %59.5). Karın ağrısıyla başvuran hastalarda, ek semptom varsa %30.6, ek semptom yoksa %62.9 oranında kolonoskopi sonucunun normal olduğu saptandı (p=0.032). İki hastada (%0.04) spontan perforasyon görüldü. Sonuç: Kolonoskopi doğru endikasyonla yapıldığında güvenilir bir yöntemidir. Özellikle karın ağrısıyla başvuran hastalarda, ek semptomların varlığı araştırılmalıdır. Çalışmamızda en sık saptanan hastalığın İBH olduğu ve sıklığın giderek artacağı öngörülmektedir ancak daha kesin sonuçlar için çok merkezli epidemiyolojik çalışmalara ihtiyaç vardır.
- 15 December 2021
- Published by Mersin Universitesi Saglik Bilimleri Dergisi in Mersin Üniversitesi Sağlık Bilimleri Dergisi
- Vol. 14 (3) , 475-483
Open AccessAssessment of colonoscopic findings in pediatric patients; A single center experience
Amaç: Çalışmada, kolonoskopi yapılan çocuk hastalarda başvuru semptomları, işlem endikasyonları, sonuçlar ve komplikasyonların değerlendirilmesi amaçlandı. Yöntem: Çalışmaya Ocak 2008 ile Aralık 2020 tarihleri arasında kolonoskopi yapılan 0-18 yaş arası hastalar dahil edildi. Hastaların demografik özellikleri, kolonoskopi ve patoloji sonuçları geriye dönük incelendi. Bulgular: Çalışmaya dahil edilen 489 hastanın ortalama yaşı 12.39±4.32 yıl, %57.4’ü erkek, %42.6’sı kızdı. Hastaların 408’inde ≥1 semptom vardı. En sık üç semptom; rektal kanama (n=265, %54.1), karın ağrısı (n=187, %38.2) ve kanlı mukuslu dışkılamaydı (n=112, %22.9). Başlıca kolonoskopi endikasyonu inflamatuvar bağırsak hastalığı (İBH) şüphesi (n=212, %43.3), alt gastrointestinal sistemde kanama (n=145, %29.6) ve kronik ishaldi (n=59, %12). En sık iki tanı İBH (n=88, %17.9) ve polipti (n=31,%6.3). İnflamatuvar bağırsak hastalığı saptananların 46’sında (%9.4) ülseratif kolit, 32’sinde (%6.5) Crohn hastalığı ve 11’inde (%2.2) sınıflandırılamayan İBH olduğu belirlendi. Poliplerin en sık (%74.1) rektosigmoid kolonda yerleşim gösterdiği, %61.2’sinin juvenil polip olduğu saptandı. Sonuçları normal olan 272 (%55.6) hastada en sık iki semptomun rektal kanama (n=91, %62.7) ve ishal (n=31, %52.5), en sık bulgunun da anemi olduğu saptandı (n=25, %59.5). Karın ağrısıyla başvuran hastalarda, ek semptom varsa %30.6, ek semptom yoksa %62.9 oranında kolonoskopi sonucunun normal olduğu saptandı (p=0.032). İki hastada (%0.04) spontan perforasyon görüldü. Sonuç: Kolonoskopi doğru endikasyonla yapıldığında güvenilir bir yöntemidir. Özellikle karın ağrısıyla başvuran hastalarda, ek semptomların varlığı araştırılmalıdır. Çalışmamızda en sık saptanan hastalığın İBH olduğu ve sıklığın giderek artacağı öngörülmektedir ancak daha kesin sonuçlar için çok merkezli epidemiyolojik çalışmalara ihtiyaç vardır.